当前位置:首页 - 行情中心 - 海森药业(001367) - 财务分析 - 现金流量表

海森药业

(001367)

  

流通市值:26.04亿  总市值:32.62亿
流通股本:1.22亿   总股本:1.52亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金200,066,169.4693,936,790.22394,681,831.03295,538,019.6
  收到的税费返还4,642,541.654,005,696.1812,593,342.986,633,093.62
  收到其他与经营活动有关的现金2,224,725.261,192,607.8615,588,954.548,512,647.72
  经营活动现金流入小计206,933,436.3799,135,094.26422,864,128.55310,683,760.94
  购买商品、接受劳务支付的现金55,115,714.7930,956,838.8108,631,921.36104,370,799.09
  支付给职工以及为职工支付的现金47,592,511.6527,537,221.9480,588,504.9161,552,094.22
  支付的各项税费19,227,284.239,730,403.3621,525,818.4819,455,575.87
  支付其他与经营活动有关的现金9,532,740.494,626,084.8934,664,292.7818,101,074.54
  经营活动现金流出小计131,468,251.1672,850,548.99245,410,537.53203,479,543.72
  经营活动产生的现金流量净额75,465,185.2126,284,545.27177,453,591.02107,204,217.22
二、投资活动产生的现金流量:
  收回投资收到的现金903,745,237.74652,968,525.411,943,017,801.561,260,661,019.51
  投资活动现金流入小计903,745,237.74652,968,525.411,943,017,801.561,260,661,019.51
  购建固定资产、无形资产和其他长期资产支付的现金22,568,052.79,032,126.83152,263,155.87138,557,108.37
  投资支付的现金1,370,000,000770,000,0002,088,000,0001,748,000,000
  投资活动现金流出小计1,392,568,052.7779,032,126.832,240,263,155.871,886,557,108.37
  投资活动产生的现金流量净额-488,822,814.96-126,063,601.42-297,245,354.31-625,896,088.86
三、筹资活动产生的现金流量:
  吸收投资收到的现金--3,580,726.83,580,726.8
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--3,580,726.83,580,726.8
  分配股利、利润或偿付利息支付的现金17,672,739.2-17,451,01017,451,010
  支付其他与筹资活动有关的现金88,560-1,723,765273,735
  筹资活动现金流出平衡项目0-00
  筹资活动现金流出小计17,761,299.2-19,174,77517,724,745
  筹资活动产生的现金流量净额平衡项目0-00
  筹资活动产生的现金流量净额-17,761,299.2--15,594,048.2-14,144,018.2
四、汇率变动对现金及现金等价物的影响-740,008.61-450,359.4912,993.881,242,771.26
五、现金及现金等价物净增加额-431,858,937.56-100,229,415.55-134,472,817.61-531,593,118.58
  加:期初现金及现金等价物余额900,009,294.67900,009,294.671,034,482,112.281,034,482,112.28
  期末现金及现金等价物余额468,150,357.11799,779,879.12900,009,294.67502,888,993.7
补充资料:
  净利润65,735,351.14-135,879,665.78-
  资产减值准备-1,530,074.83-3,451,459.11-
  固定资产和投资性房地产折旧11,282,004.81-19,744,823.14-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧11,282,004.81-19,744,823.14-
  无形资产摊销1,491,595.88-2,310,675.37-
  长期待摊费用摊销286,687.83-468,106.08-
  固定资产报废损失55,460.89-400,279.01-
  公允价值变动损失---1,695,000-
  财务费用2,449,513.77-397,911.99-
  投资损失-2,050,237.74--5,017,801.56-
  递延所得税-1,862,033.13-1,656,928.64-
  其中:递延所得税资产减少---565,390.76-
    递延所得税负债增加-1,862,033.13-2,222,319.4-
  存货的减少1,460,413.4--3,047,456.02-
  经营性应收项目的减少7,991,312.15--16,481,382.23-
  经营性应付项目的增加-16,837,791.64-17,169,393.06-
  其他6,181,872.68-20,711,020.83-
  现金的期末余额468,150,357.11-820,009,294.67-
  减:现金的期初余额900,009,294.67-1,034,482,112.28-
  加:现金等价物的期末余额--80,000,000-
  现金及现金等价物的净增加额-431,858,937.56--134,472,817.61-
公告日期2026-08-212026-04-282026-03-262025-10-22
审计意见(境内)标准无保留意见
TOP↑